FDA Approves Trodelvy, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 7, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to Trodelvy® (sacituzumab govitecan-hziy) for adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies, at least one of them for metastatic disease. The approval is supported by data […]

Read more

Missouri ‘Voted for This Lie,’ Says State Rep Trying to Block Medicaid Expansion

It is hard to qualify for Medicaid as an adult in Missouri. Single adults aren’t eligible for coverage through the state’s program — dubbed MO HealthNet — at all, and parents can’t make more than 21% of the federal poverty level: $5,400 in 2021 for a family of three. That was all set to change on July 1 because of […]

Read more

Terry White Chemists Clomipramine

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS CLOMIPRAMINE Contains the active ingredient, clomipramine (as clomipramine hydrochloride) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about clomipramine. It does not contain all the available information.It does not take […]

Read more

Zovirax Ophthalmic Ointment

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZOVIRAX OPHTHALMIC (EYE) OINTMENT Acyclovir Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Zovirax ophthalmic ointment. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

Read more

Water for Injections

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. WATER FOR INJECTIONS BP Consumer Medicine Information What is in this leaflet? This leaflet answers some of the common questions people ask about WATER FOR INJECTIONS BP.It does not contain all the information that is known about WATER FOR INJECTIONS BP. It does not take the place […]

Read more

Steglatro

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. STEGLATRO® This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems. Ertugliflozin pyroglutamic acid Consumer Medicine Information What is in […]

Read more

Trajenta

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRAJENTA CMI0133-09 Tablets linagliptin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Trajenta. It does not contain all the available information. It does not take the place of talking to your doctor, pharmacist or diabetes educator. All medicines have risks […]

Read more

Terry White Chemists Meloxicam

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS MELOXICAM TABLETS Contains the active ingredient, meloxicam Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about meloxicam. It does not contain all the available information. It does not take the […]

Read more

Metopirone

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. METOPIRONE® metyrapone Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Metopirone. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated […]

Read more

Olumiant

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OLUMIANT® This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems  baricitinib tablets Consumer Medicine Information What is in this […]

Read more
1 2 3 20